Neuronetics Inc - Asset Resilience Ratio
Neuronetics Inc (STIM) has an Asset Resilience Ratio of 0.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Neuronetics Inc's Asset Resilience Ratio has changed over time. Check STIM strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Neuronetics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Neuronetics Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $257.00K | 0.2% |
| Total Liquid Assets | $257.00K | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Neuronetics Inc maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neuronetics Inc Industry Peers by Asset Resilience Ratio
Compare Neuronetics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Scibase AB
ST:SCIB |
Medical Devices | 43.33% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 33.68% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Vieworks Co. Ltd
KQ:100120 |
Medical Devices | 7.81% |
Annual Asset Resilience Ratio for Neuronetics Inc (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Neuronetics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.16% | $225.00K | $141.55 Million | +0.01pp |
| 2024-12-31 | 0.15% | $206.00K | $140.90 Million | -0.64pp |
| 2023-12-31 | 0.78% | $905.00K | $115.83 Million | -0.53pp |
| 2022-12-31 | 1.32% | $1.54 Million | $116.88 Million | -0.24pp |
| 2021-12-31 | 1.56% | $2.20 Million | $141.22 Million | -0.84pp |
| 2020-12-31 | 2.40% | $1.89 Million | $78.66 Million | +1.52pp |
| 2019-12-31 | 0.88% | $880.00K | $100.17 Million | -- |
About Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a p… Read more